Effect of Agaricus brasiliensis S. Wasser et al. (Agarico-mycetideae) on murine diabetic model C57BL/Ksj-db/db

International Journal of Medicinal Mushrooms

Volumn 8, Issue 2, 2006, Pages 115-128

  Furukawa, Mai ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Motoi, Masuro ^b   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b Toei Pharmaceutical Co Ltd   (Japan)

Author keywords

Agaricus brasiliensis; C57Bl ksj db db; Cold water extract; Diabetic nephropathy; Peroxidase; Polyphenoloxidase

Indexed keywords

AGARICUS BRASILIENSIS EXTRACT; BETA 1,3 GLUCAN; CONCANAVALIN A; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NATURAL PRODUCT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

AGARICOMYCETIDEAE; AGARICUS; AGARICUS BRASILIENSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FRUITING BODY; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; MALE; MOUSE; MUSHROOM; NATURAL KILLER CELL; NONHUMAN; ORGAN WEIGHT; RENAL PROTECTION; SPLEEN CELL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TISSUE SECTION; TREATMENT OUTCOME; URINE PH;

AGARICUS BRASILIENSIS; BASIDIOMYCOTA; MURINAE;

EID: 33749032141     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v8.i2.30     Document Type: Article

References (52)

1. Ahmed S., Anuntiyo J., Malemud C. J., and Haqqi T. M. 2005. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med, 2, 301-308.
2. Akanuma M. A., Yamagishi A., Motoi M., and Ohno N. 2006. Cloning and characterization of polyphenoloxidase DNA from A. brasiliensis. Int J Med Mushr, 8, 67-76.
3. Ahn W. S., Kim D. J., Chae G. T., Lee J. M., Bae S. M., Sin J. I., Kim Y. W., Namkoong S. E., and Lee I. P. 2004. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murrill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer, 14(4), 589-594.
4. Anstee Q. M. and Goldin R. D. 2006. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol, 87, 1-16.
5. Bellini M. F., Giacomini N. L., Eira A. F., Ribeiro L. R., and Mantovani M. S. 2003. Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO-k1 cells, studying different developmental phases of the mushroom. Toxicol In Vitro, 17(4), 465-469.
6. Berglund O., Frankel B. J., and Hellman B. 1978. Development of the insulin secretory defect in genetically diabetic (db/db) mouse. Acta Endocrinol (Copenh), 87, 543-551.
7. Breyer M. D., Bottinger E., Brosius F. C. 3rd, Coffman T. M., Harris R. C., Heilig C. W., and Sharma K. 2005a. Mouse models of diabetic nephropathy. J Am Soc Nephrol, 16, 27-45.
8. Breyer M. D., Bottinger E., Brosius F. C., Coffman T. M., Fogo A., Harris R. C., Heilig C. W., and Sharma K. 2005b. Diabetic nephropathy: of mice and men. Adv Chronic Kidney Dis, 12, 128-145.
9. Capodice J. L., Bemis D. L., Buttyan R., Kaplan S. A., and Katz A. E. 2005. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid Based Complement Alternat Med, 2, 495-501.
10. Delmanto R. D., de Lima P. L., Sugui M. M., da Eira A. F., Salvadori D. M., Speit G., and Ribeiro L. R. 2001. Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide. Mutat Res, 496(1-2), 15-21.
11. Didukh M. Ya., Wasser S. P., and Nevo E. 2003. Medicinal value of species of the family Agaricaceae Cohn (Higher Basidiomycetes): current state of knowledge and future perspectives. Int J Med Mushr, 5, 133-152.
12. Didukh M. Ya., Wasser S. P., and Nevo E. 2004. Impact of the family Agaricaceae on nutrition and medicine. A.R.G. Gantner Verlag K.G., Ruggell, 205 pp.
13. Guterrez Z. R., Mantovani M. S., Eira A. F., Ribeiro L. R., and Jordao B. Q. 2004. Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murrill in vitro. Toxicol In Vitro, 18(3), 301-309.
14. Haddad P. S., Azar G. A., Groom S., and Boivin M. 2005. Natural health products, modulation of immune function and prevention of chronic diseases. Evid Based Complement Alternat Med, 2, 513-520.
15. Hashimoto S., Akanuma M. A., Motoi M., Imai N., Rodrignes C. A., Nameda S., Miura N. N., Adachi Y., and Ohno N. 2006. Effect of culture conditions on chemical composition and biological activities of Agaricus brasiliensis S.Wasser et al. (Agaricomycetideae). Int J Med Mushr, (in press).
16. Hashimoto T., Nonaka Y., Minato K., Kawakami S., Mizuno M., Fukuda I., Kanazawa K., and Ashida H. 2002. Suppressive effect of polysaccharides from the edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice. Biosci Biotechnol Biochem, 66(7), 1610-1614.
17. Hummel K. P. 1970. Hypodactyly, a semidominant lethal mutation in mice. J Hered, 61, 219-220.
18. Hummel K. P., Coleman D. L., and Lane P. W. 1972. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL-6J strains. Biochem Genet, 7, 1-13.
19. Ito H., Shimura K., Itoh H., and Kawade M. 1997. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) "Himematsutake" and its mechanisms in tumor-bearing mice. Anticancer Res, 17, 277-284.
20. Itoh H., Ito H., Amano H., and Noda H. 1994. Inhibitory action of a (1 - >6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murrill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol, 66, 265-271.
21. Izawa S. and Inoue Y. 2004. A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murrill. Appl Microbiol Biotechnol, 64(4), 537-542.
22. Kasai H., He L. M., Kawamura M., Yang P. T., Deng X. W., Munkanta M., Yamashita A., Terunuma H., Hirama M., Horiuchi I., Natori T., Koga T., Amano Y., Yamaguchi N., and Ito M. 2004. IL-12 production induced by Agaricus blazei fraction H (ABH) involves toll-like receptor (TLR). Evid Based Complement Alternat Med, 1, 259-267.
23. Kawagishi H., Inagaki R., Kanao T., Mizuno T., Shimura K., Ito H., Hagiwara T., and Nakamura T. 1989. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res, 186(2), 267-273.
24. Kawagishi H., Nomura A., Yumen T., Mizuno T., Hagiwara T., and Nakamura T. 1988. Isolation and properties of a lectin from the fruiting bodies of Agaricus blazei. Carbohydr Res, 183(1), 150-154.
25. Ker Y. B., Chen K. C., Chyau C. C., Chen C. C., Guo J. H., Hsieh C. L., Wang H. E., Peng C. C., Chang C. H., and Peng R. Y. 2005. Antioxidant capability of polysaccharides fractionated from submerge-cultured Agaricus blazei mycelia. J Agric Food Chem, 53, 7052-7058.
26. Kim G. Y., Lee M. Y., Lee H. J., Moon D. O., Lee C. M., Jin C. Y., Choi Y. H., Jeong Y. K., Chung K. T., Lee J. Y., Choi I. H., and Park Y. M. 2005a. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol, 5, 1523-1532.
27. Kim Y. W., Kim K. H., Choi H. J., and Lee D. S. 2005b. Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett, 27, 483-487.
28. Kimura Y. 2005. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo, 19(1), 37-60.
29. Kimura Y., Kido T., Takaku T., Sumiyoshi M., and Baba K. 2004. Isolation of an anti-angiogenic substance from Agaricus blazei Murrill: its antitumor and antimetastatic actions. Cancer Sci, 95(9), 758-764.
30. Kobayashi H., Yoshida R., Kanada Y., Fukuda Y., Yagyu T., Inagaki K., Kondo T., Kurita N., Suzuki M., Kanayama N., and Terao T. 2005. Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murrill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol, 131, 527-538.
31. Kubo N., Myojin Y., Shimamoto F., Kashimoto N., Kyo E., Kamiya K., and Watanabe H. 2005. Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei Murrill against X-irradiation in B6C3F1 mice: Increased small intestinal crypt survival and prolongation of average time to animal death. Int J Mol Med, 15(3), 401-406.
32. Kuo Y. C., Huang Y. L., Chen C. C., Lin Y. S., Chuang K. A., and Tsai W. J. 2002. Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei. J Lab Clin Med, 140(3), 176-187.
33. Kuhn-Velten N., Codjambopoulo P., Herberg L., Kley H. K., and Staib W. 1985. In vitro studies of the development of pituitary and testicular functions in diabetes (C57Bl/KsJ-db/db) mutant mice. Horm Metab Res, 17, 576-579.
34. Lee S. M. and Bressler R. 1981. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes, 30, 106-111.
35. Lindequist U., Niedermeyer T. H., and Julich W. D. 2005. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med, 2, 285-299.
36. Masiello P. 2006. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol, 38, 873-893.
37. Mizuno M., Minato K., Ito H., Kawade M., Terai H., and Tsuchida H. 1999. Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei Murr. Biochem Mol Biol Int, 47(4), 707-714.
38. Mizuno M., Morimoto M., Minato K., and Tsuchida H. 1998. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem, 62, 434-437.
39. Nathanielsz P. W. 2006. Animal models that elucidate basic principles of the developmental origins of adult diseases. ILAR J, 47, 73-82.
40. Ohno N., Furukawa M., Miura N. N., Adachi Y., Motoi M., and Yadomae T. 2001. Antitumor beta glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull, 24(7), 820-828.
41. Osaki Y., Kato T., Yamamoto K., Okubo J., and Miyazaki T. 1994. Antimutagenic and bactericidal substances in the fruit body of a Basidiomycete Agaricus blazei, Jun-17. Yakugaku Zasshi, 114(5), 342-350.
42. Patwardhan B., Warude D., Pushpangadan P., and Bhatt N. 2005. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med, 2, 465-473.
43. Pietras R. J. and Weinberg O. K. 2005. Antiangiogenic steroids in human cancer therapy. Evid Based Complement Alternat Med, 2, 49-57.
44. Saad B., Azaizeh H., and Said O. 2005. Tradition and perspectives of Arab herbal medicine: a review. Evid Based Complement Alternat Med, 2, 475-479.
45. Serreze D. V., Leiter E. H., Kuff E. L., Jardieu P., and Ishizaka K. 1988. Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes, 37, 351-358.
46. Sharma K., McCue P., and Dunn S. R. 2003. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol, 284, F1138-1144.
47. Shimizu S., Kitada H., Yokota H., Yamakawa J., Murayama T., Sugiyama K., Izumi H., and Yamaguchi N. 2002. Activation of the alternative complement pathway by Agaricus blazei Murrill. Phytomedicine, 9(6), 536-545.
48. Shu C. H. and Wen B. J. 2003. Enhanced shear protection and increased production of an anti-tumor polysaccharide by Agaricus blazei in xanthan-supplemented cultures. Biotechnol Lett, 25(11), 873-876.
49. Talorete T. P., Isoda H., and Maekawa T. 2002. Agaricus blazei (class Basidiomycotina) aqueous extract enhances the expression of c-Jun protein in MCF7 cells. J Agric Food Chem, 50(18), 5162-5166.
50. Ullrich R., Huong L. M., Dung N. L., and Hofrichter M. 2005. Laccase from the medicinal mushroom Agaricus blazei: production, purification and characterization. Appl Microbiol Biotechnol, 67, 357-363.
51. Wasser S. P., Didukh M. Y., de A. Amazonas M. L. A., Nevo E., Stamets P., and da Eira A. F. 2002. Is a widely cultivated culinary-medicinal Royal Sun Agaricus (the Himematsutake mushroom) indeed Agaricus blazei Murrill? Int J Med Mushr, 4(4), 267-290.
52. Xing Z., Guo Q., Feng Z., Guo L., and Liu Y. 2003. Analysis on the volatile flavor compounds in Agaricus blazei by GC-MS. Zhong Yao Cai, 26(11), 789-791.